Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection

Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection

Abstract Human respiratory syncytial virus (hRSV) infection is a major pediatric health concern worldwide. Despite more than half a century of efforts, there is still no commercially available vaccine. In this study, we constructed and purified the recombinant protein CTA1-DD-RBF composed of a CTA1-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hai Li, Hu Ren, Yan Zhang, Lei Cao, Wenbo Xu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/9512abb0d1d1466aa2d0fd8aa6ebb7a2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares